Literature DB >> 1311706

Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice.

J A Johnson1, P Panigrahi, J G Morris.   

Abstract

Non-O1 Vibrio cholerae produced two distinct colony types, designated as opaque and translucent. NRT36S, a clinical isolate shown to be virulent in volunteers, produced predominantly opaque colonies, but translucent colonies appeared on subculture. Opaque variants were recovered exclusively following exposure to normal human serum or animal passage. A nonreverting translucent mutant of NRT36S, JVB52, was isolated following mutagenesis with the transposon Tn5 IS50L::phoA (TnphoA). Only translucent colonies were produced by a nonpathogenic environmental isolate, A5. Electron microscopic examination of the opaque form of NRT36S revealed thick, electron-dense, fibrous capsules surrounding polycationic ferritin-stained cells. The ferritin-stained material around translucent NRT36S or A5 was patchy or absent. JVB52 had a thin but contiguous capsular layer. The amount of ferritin-stained capsular material correlated with the amount of surface polysaccharide determined by phenol-sulfuric acid assay: opaque NRT36S had approximately three times as much polysaccharide as translucent NRT36S or A5 and four times as much as JVB52. The encapsulated, opaque variant of NRT36S was protected from serum bactericidal activity, while translucent non-O1 V. cholerae was readily killed. The encapsulated form also had increased virulence in mice. Our data provide the first indication that non-O1 V. cholerae strains can have a polysaccharide capsule. This capsule may be important in protecting the organism from host defenses and may contribute to the ability of some non-O1 V. cholerae strains to cause septicemia in susceptible hosts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311706      PMCID: PMC257566          DOI: 10.1128/iai.60.3.864-869.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.

Authors:  R J Roantree; L A Rantz
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

Review 2.  The biologic significance of bacterial encapsulation.

Authors:  A S Cross
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus.

Authors:  S Yoshida; M Ogawa; Y Mizuguchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

4.  Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans.

Authors:  J G Morris; T Takeda; B D Tall; G A Losonsky; S K Bhattacharya; B D Forrest; B A Kay; M Nishibuchi
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 5.  Virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

6.  Development of an in vitro model for study of non-O1 Vibrio cholerae virulence using Caco-2 cells.

Authors:  P Panigrahi; B D Tall; R G Russell; L J Detolla; J G Morris
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

7.  Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.

Authors:  J Fierer; F Finley
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.

Authors:  M L Tamplin; S Specter; G E Rodrick; H Friedman
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

9.  Resistance of Vibrio vulnificus to serum bactericidal and opsonizing factors: relation to virulence in suckling mice and humans.

Authors:  D E Johnson; F M Calia; D M Musher; A Goree
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

10.  Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases.

Authors:  J G Morris; R Wilson; B R Davis; I K Wachsmuth; C F Riddle; H G Wathen; R A Pollard; P A Blake
Journal:  Ann Intern Med       Date:  1981-05       Impact factor: 25.391

View more
  25 in total

1.  Genotype and phenotypes of an intestine-adapted Escherichia coli K-12 mutant selected by animal passage for superior colonization.

Authors:  Andrew J Fabich; Mary P Leatham; Joe E Grissom; Graham Wiley; Hongshing Lai; Fares Najar; Bruce A Roe; Paul S Cohen; Tyrrell Conway
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

2.  vttRA and vttRB Encode ToxR family proteins that mediate bile-induced expression of type three secretion system genes in a non-O1/non-O139 Vibrio cholerae strain.

Authors:  Ashfaqul Alam; Vincent Tam; Elaine Hamilton; Michelle Dziejman
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

3.  Quorum sensing and silencing in Vibrio parahaemolyticus.

Authors:  Cindy J Gode-Potratz; Linda L McCarter
Journal:  J Bacteriol       Date:  2011-06-24       Impact factor: 3.490

4.  Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences.

Authors:  J A Johnson; C A Salles; P Panigrahi; M J Albert; A C Wright; R J Johnson; J G Morris
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 5.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

6.  Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis.

Authors:  S R Attridge; F Qadri; M J Albert; P A Manning
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Salmonella enterica serovar Typhimurium DT104 displays a rugose phenotype.

Authors:  Y A Anriany; R M Weiner; J A Johnson; C E De Rezende; S W Joseph
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

8.  Evidence for the Adhesive Function of the Exopolysaccharide of Hyphomonas Strain MHS-3 in Its Attachment to Surfaces.

Authors:  E J Quintero; R M Weiner
Journal:  Appl Environ Microbiol       Date:  1995-05       Impact factor: 4.792

9.  The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.

Authors:  M K Waldor; R Colwell; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  Further characterization of Vibrio vulnificus rugose variants and identification of a capsular and rugose exopolysaccharide gene cluster.

Authors:  Brenda L Grau; Margaret C Henk; Katherine L Garrison; Brett J Olivier; Randall M Schulz; Kathy L O'Reilly; Gregg S Pettis
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.